Study guide
8.6 Prescription Labeling: Oregon Elements, Physical Description, Expiration Dating & Med Paks
Oregon Multistate Pharmacy Jurisprudence Examination MPJE
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Overview & Oregon Legal Framework
1.1 Oregon MPJE Format, Fees, Blueprint & 2027 Changes 1.2 Federal–Oregon Legal Hierarchy, Agencies & the Board of Pharmacy
2 Chapter 2: Pharmacist & Pharmacist-in-Charge Responsibilities
2.1 Pharmacist Responsibilities, Supervision & Prohibited Practices 2.2 Pharmacist-in-Charge: Qualifications, Duties, Inventories & Self-Inspection
3 Chapter 3: Pharmacy Technicians, Interns & Preceptors
3.1 Pharmacy Technicians (COPT & PT): Licensure, Permitted Tasks & Limits 3.2 Pharmacy Interns & Preceptors: Licensure, Scope & Supervision
4 Chapter 4: Licensure, Renewal, Discipline & Impaired Practitioners
4.1 Pharmacist Licensure by Examination, Score Transfer & Reciprocity 4.2 License Renewal, Continuing Pharmacy Education & Lapse Rules 4.3 Grounds for Discipline, Sanctions & Mandatory Reporting Deadlines 4.4 Impaired Practitioners & the Health Professionals' Services Program (HPSP)
5 Chapter 5: Prescriber Authority & Prescription Requirements
5.1 Prescriber Authority, DEA Registration & Out-of-State Prescriptions 5.2 Non-Controlled Prescriptions: Required Elements, Signatures, Expiration & Refills 5.3 Controlled Substance Prescriptions: Schedules II–V, EPCS, Emergency Orders & Oregon's CV Limit 5.4 Drug-Use Limitations & Special Prescriptions: REMS, Death with Dignity, EPT & Standing Orders 5.5 Legitimate Medical Purpose, Corresponding Responsibility & Red Flags
6 Chapter 6: Pharmacist Clinical Services & Prescriptive Authority
6.1 CDTM, Clinical Pharmacy Agreements, MTM & Laboratory Testing 6.2 Pharmacist Prescribing: Statewide Protocols, the Formulary & General Requirements 6.3 Pharmacist Prescribing of Hormonal Contraception (ORS 689.689) 6.4 Tobacco Cessation Protocol: Training, Screening, NRT & Non-NRT Prescribing 6.5 Vaccine Prescribing & Administration: Age Floors, Protocols, Training & ALERT IIS 6.6 Opioid Overdose Reversal & MOUD: Naloxone Prescribing, Standing Orders, Immunity & Buprenorphine
7 Chapter 7: Counseling, Language Access & Confidentiality
7.1 Patient Counseling: Triggers, Who May Offer or Accept a Refusal & Documentation 7.2 Language Access & Accessibility: Dual-Language Labels, Registry Interpreters & Prescription Readers 7.3 Patient Confidentiality: Oregon Rules, HIPAA, Part 2 & PDMP Privacy
8 Chapter 8: The Dispensing Process
8.1 Prospective Drug Utilization Review: Oregon's Eight Categories, Documentation & Who May Perform It 8.2 Oregon PDMP: Reporting Within 72 Hours, Covered Drugs, Access & Confidentiality 8.3 Prescription Transfers: Oregon's Next-Business-Day Duty & Federal Controlled Substance Limits 8.4 Dispensing Exceptions: 72-Hour Emergency Refills, Continuation of Therapy, Insulin & Declared Emergencies 8.5 Partial Fills: Schedule II (72-Hour, 30-Day CARA & 60-Day LTCF/Terminal) and Schedules III–V 8.6 Prescription Labeling: Oregon Elements, Physical Description, Expiration Dating & Med Paks 8.7 Packaging: PPPA Child-Resistant Containers, Waivers, Exemptions & Oregon's New-Container Rule 8.8 Conditions Prohibiting Dispensing, Quarantine, Returned Drugs & Charitable Reuse
9 Chapter 9: Nonprescription & Restricted Products
9.1 Nonprescription Drugs: Outlet Registration, Drug Facts Labeling & OTC Packaging 9.2 Dispensing-Restricted Nonprescription Products: Pseudoephedrine, Exempt Schedule V & Others
10 Chapter 10: Product Selection: Generic & Biologic Substitution
10.1 Product Selection: Generic Substitution (ORS 689.515) & Biologic Interchange (ORS 689.522)
11 Chapter 11: Acquisition, Records, Inventories & Loss Reporting
11.1 Ordering & Acquiring Controlled Substances: DEA Registration, Form 222, CSOS & the 5% Rule 11.2 Distribution Records, DSCSA, Recalls & Oregon Record Retention 11.3 Controlled Substance Inventories: Oregon's 367-Day, 93-Day, 31-Day & 15-Day Rules 11.4 Theft & Loss Reporting, Disposal, Reverse Distribution & Take-Back Receptacles
12 Chapter 12: Pharmacy Operations, Storage, Security & Special Practice Settings
12.1 Pharmacy Operations: Pharmacist Presence, Policies, Equipment, Signage, Hours & Closures 12.2 Drug Storage & Cold Chain: Temperatures, Monitoring Plans, Excursions & Vaccine Units 12.3 Security & Non-Pharmacist Access: Keys, Double Set-Ups, Institutional Night Access & DEA Controls 12.4 Hazardous Drugs: NIOSH 2024 List, USP 800 Controls, Assessment of Risk & Disposal 12.5 Compounding: OAR 855-183 (June 2026), USP 795/797/800, 503A vs. 503B & Beyond-Use Dates 12.6 Delivery of Drugs: Depots, Mail Delivery, Prescription Lockers, Kiosks & Mobile Pharmacies 12.7 Central Fill, Remote Processing, Telework & Remote Dispensing Site Pharmacies
13 Chapter 13: Drug Outlet Registration, Inspection & Institutional Practice
13.1 Drug Outlet Classes, Registration, Changes of Ownership/Location/Name & Non-Resident Pharmacies 13.2 Inspections, Self-Inspection Forms & Discipline of Drug Outlets 13.3 Institutional & Long-Term Care Practice: Drug Rooms, Night Access, E-Kits, ADCs & ED Prepacks
8.6 Prescription Labeling: Oregon Elements, Physical Description, Expiration Dating & Med Paks
Key Takeaways Explain This Topic AI
An Oregon prescription label must include the pharmacy's name, address and phone, the fill date, Rx number, patient, drug and strength, quantity, directions, practitioner, precautions, expiration date and physical description.
When an Oregon pharmacy dispenses a generic, the label must also identify the manufacturer or distributor (ORS 689.505; ORS 689.515).
Under OAR 855-041-1130(12), Oregon labels must describe the drug's appearance, including imprint codes, unless it is dispensed in unit-dose or unit-of-use packaging.
An Oregon label's expiration date may not exceed the earlier of the manufacturer's date or one year from repackaging and dispensing, and a drug that expires before therapy ends may not be dispensed.
Oregon customized patient med paks carry a beyond-use date no later than 60 days from preparation, in Class B containers, with each drug's physical description.
Last updated: October 2026
Why this matters
Area 3.5 covers labeling of dispensed drugs. Oregon's label requirements come from ORS 689.505, ORS 689.515 and OAR 855-041-1130 . Oregon requires a physical description of the drug on most labels and limits expiration dating in specific ways. Federal law adds the controlled-substance warning.
Required label elements for drugs dispensed to a patient (OAR 855-041-1130)
- Element Notes
- Pharmacy name, address and telephone number
- Date of fill
- Identifying (prescription) number
- Patient name Except under expedited partner therapy (ORS 689.505(5)(d))
Drug name and strength, and quantity dispensed If a generic name is used, the label must also identify the manufacturer or distributor (ORS 689.505(5)(a); ORS 689.515(7))
- Directions for use As stated in the prescription
- Name of the practitioner
Required precautionary information Auxiliary and federal warnings, such as the controlled-substance transfer warning below
Expiration date See below
Physical description Including any identification code on tablets and capsules, unless dispensed in unit-dose or unit-of-use packaging (OAR 855-041-1130(12))
A prescriber may direct that the label not state the drug's name and quantity per unit (ORS 689.505(6)). The pharmacy then labels as the prescriber intended (ORS 689.515(8)).
Expiration dating (OAR 855-041-1130(10)–(11))
The expiration date on the label may not exceed:
The date on the manufacturer's container, if the drug is dispensed in the manufacturer's container ; or
Otherwise, the earlier of the manufacturer's expiration date or one year from the date the drug was repackaged and dispensed .
A drug that will expire before the expected course of therapy ends must not be dispensed .
Federal controlled-substance labeling
For Schedule II–IV drugs dispensed to a patient, federal law requires the warning "Caution: Federal law prohibits the transfer of this drug to any person other than the patient for whom it was prescribed" (21 CFR 290.5). The label must also show the pharmacy name and address, serial number, date of initial filling, patient name, prescriber name, directions and cautionary statements (21 CFR 1306.14, 1306.24). Oregon's elements already cover most of these.
Dual-language and accessible labels
On request of the prescriber, patient or agent, the label must be in English plus one of Oregon's 14 languages , and must be compatible with any prescription reader provided (section 7.2).
Labels for repackaged drugs and patient med paks
Repackaged drugs for later dispensing (OAR 855-041-1135) must show:
The brand name, or the generic name and manufacturer.
The strength and the lot number .
The manufacturer's expiration date, or an earlier date the pharmacist judges preferable.
An internal control number may link to the manufacturer and lot. Containers must meet USP standards. A technician or intern who labels repackaged drugs, or returns drugs to stock, needs pharmacist verification documented.
Customized patient medication packages ("med paks," OAR 855-041-1140) hold several solid oral drugs for one patient. The label shows:
The patient's name and a serial number.
For each drug: its name, strength, physical description and quantity, plus its directions, cautionary statements and prescriber.
Storage instructions, and the date of preparation and beyond-use date , which may be no later than 60 days from preparation.
The dispenser's name, address and phone.
Med paks use Class B moisture-permeation containers, meet PPPA requirements and come with package inserts or educational material. The pharmacist checks the drugs' compatibility.
Other labeling situations
Generic substitution: the label names the drug dispensed , or the generic name plus the manufacturer (ORS 689.515(7)).
Nasal opioid antagonists dispensed by a pharmacist prescriber are exempt from some labeling requirements (ORS 689.813; OAR 855-115-0350).
Compounded preparations: labels follow USP 795/797 and OAR 855-183 for preparation, and OAR 855-041 for dispensing.
Practitioner dispensing: NPs, CNSs and PAs who dispense must label like pharmacies (ORS 678.390(5); ORS 677.511).
Tip
On a label question, check two Oregon specifics first: is the physical description (with imprint) present, and is the expiration date no later than the earlier of the manufacturer's date or one year from dispensing? Then check the generic-name manufacturer identifier and any controlled-substance warning.
Exam scenario
An Oregon pharmacy dispenses 30 amlodipine 5 mg tablets from a bulk bottle expiring in 8 months, as a generic, in a new amber vial. The label must include all the elements above, the manufacturer's name (generic dispensed), a physical description such as "white, round, imprint ABC 5," and an expiration date no later than the manufacturer's date 8 months out (earlier than one year). If the same drug were dispensed in unit-dose blister packaging, the physical description could be omitted.